MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders

被引:0
|
作者
J-F Fu
J-Y Shi
W-L Zhao
G Li
Q Pan
J-M Li
J Hu
Z-X Shen
J Jin
F-Y Chen
S-J Chen
机构
[1] State Key Laboratory of Medical Genomics,Department of Hematology
[2] Shanghai Institute of Hematology,undefined
[3] Shanghai Rui Jin Hospital,undefined
[4] Shanghai Jiao Tong University School of Medicine,undefined
[5] Zhejiang Institute of Hematology,undefined
[6] The First Affiliated Hospital,undefined
[7] Medical School of Zhejiang University,undefined
[8] Shanghai Ren Ji Hospital,undefined
[9] Shanghai Jiao Tong University School of Medicine,undefined
来源
Leukemia | 2008年 / 22卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:660 / 663
页数:3
相关论文
共 50 条
  • [1] MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders
    Fu, J-F
    Shi, J-Y
    Zhao, W-L
    Li, G.
    Pan, Q.
    Li, J-M
    Hu, J.
    Shen, Z-X
    Jin, J.
    Chen, F-Y
    Chen, S-J
    LEUKEMIA, 2008, 22 (03) : 660 - 663
  • [2] Analysis of JAK2V617F mutation in Chinese patients with myeloproliferative disorders
    Chen, Suning
    Fei, Hairong
    Zhang, Ri
    Xue, Yongquan
    Pan, Jinlan
    Wu, Yafang
    Ceng, Jiannong
    AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (06) : 458 - 459
  • [3] JAK2V617F mutation detection in myeloproliferative disorders (MPD)
    Bakkus, M. H. C.
    Trullemans, F.
    Demanet, C.
    De Waele, M.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 110 - 110
  • [4] Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders
    Marchetti, Marina
    Falanga, Anna
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2007, 36 (3-4) : 148 - 159
  • [5] Identification of JAK2V617F Mutation on Myeloproliferative Disorders in Medan
    Anggraini, Dwi Rita
    Hidayat
    Sitorus, Mega Sari
    PROCEEDINGS OF THE 1ST PUBLIC HEALTH INTERNATIONAL CONFERENCE (PHICO 2016), 2016, 1
  • [6] Development of a real time PCR assay for the JAK2V617F mutation in myeloproliferative disorders
    Olsen, RJ
    Tang, D
    Bernard, DW
    Farkas, DH
    Chang, JCC
    MODERN PATHOLOGY, 2006, 19 : 240A - 240A
  • [7] Jak2v617f mutation as useful molecular marker for myeloproliferative disorders
    Tiberio, C.
    Sansone, M.
    Consales, C.
    Latte, A.
    Russo, A.
    Pepe, N.
    Importa, S.
    Villa, M. R.
    Mastrullo, L.
    Polistina, M. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 202 - 202
  • [8] JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis
    Qi, X.
    Hu, F.
    Yang, Z.
    Han, G.
    Fan, D.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) : 495 - 496
  • [9] JAK2V617F mutation and thrombosis in the myeloproliferative neoplasms
    Demirkan, F.
    Kalkan, S.
    Kahraman, S.
    Tunali, S.
    Katgi, A.
    Piskin, O.
    Ozcan, M. A.
    Ozsan, H. G.
    Undar, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 890 - 890
  • [10] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381